Patient Corner Logo
Patient Corner Banner

Article of the Week

CBD v. Epilepsy


CBD, along with THC, is currently at the forefront of the medical medication discussion and for very good reason. With the legal cannabis market expected to grow to $37 billion USD by the end of 2023 (1), a majority of that financial promise lies within the medicinal aspects of the plant. Cannabidiol, better known as CBD, is revered in regard to treating epileptic seizures and that’s only a partial reason for its present-day booming popularity.

There has always been evidence of CBD helping, but more clinical trials certainly need to be funded and completed. In 1980, a double-blind study consisting of 15 patients suffering from secondary generalized epilepsy with temporal focus were divided into two groups (2). One group was given 200-300mg daily of CBD and the other, a placebo – the study lasted for 4 and a half months with the patients continuing to use prior prescribed antiepileptic drugs the entire time. The results of this study dawning 39 years ago found that 4 of the 8 CBD patients remained free of convulsive episodes, 3 patients improved partially and 1 reported inefficacy altogether. Strong promise is what was shown, and that’s more than enough reason for medical cannabis research to be rewarded with as much funding necessary to continue making strides.

Let’s fast forward to the 2010s, a report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy in 2013 surfaced with a more decisive view on the matter (3). This survey was presented to parents belonging to a Facebook group in strong support of sharing CBD information which they used to treat their child’s seizures stemming from childhood epilepsy. Nineteen responses met the criteria for the study and were analyzed thoroughly; 84% of the 19 parents participating reported a reduction in their child’s seizure frequency while taking CBD prominent cannabis. Of that 84%, 11% of the parents reported complete seizure freedom and eight parents (42%) reported a greater than 80% reduction in seizure frequency.

As the landscape of the healthcare economy continues to evolve and advance, it’s clear as day that CBD is becoming an influential player in the future of medicine.